M. Tubiana-Hulin

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

Michel Marty, Francesco Cognetti, D Maraninchi et al. · IRIS UNIMORE (University of Modena and Reggio Emilia) · 2005 · 1.6K citations · Full text

Medicine, Oncology, Pharmacology +17

Identification of molecular apocrine breast tumours by microarray analysis

Pierre Farmer, Hervé Bonnefoi, Véronique Becette et al. · Oncogene · 2005 · 767 citations · Full text

Medicine, Molecular Biology, Oncology +14

Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas

V Le Doussal, M. Tubiana-Hulin, Sam Friedman et al. · Cancer · 1989 · 373 citations

Medicine, Oncology, Pathology +17

Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial

Per Eystein Lønning, Emilio Bajetta, Robin Murray et al. · Journal of Clinical Oncology · 2000 · 318 citations

Medicine, Oncology, Pharmacology +16

Practical guidance for the management of aromatase inhibitor-associated bone loss

Peyman Hadji, J.J. Body, Matti Aapro et al. · Annals of Oncology · 2008 · 226 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +14